Exact Mass: 371.1304

Exact Mass Matches: 371.1304

Found 15 metabolites which its exact mass value is equals to given mass value 371.1304, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

(3z)-N,N-Dimethyl-2-Oxo-3-(4,5,6,7-Tetrahydro-1h-Indol-2-Ylmethylidene)-2,3-Dihydro-1h-Indole-5-Sulfonamide

(3Z)-N,N-Dimethyl-2-oxo-3-(4,5,6,7-tetrahydro-1H-indol-2-ylmethylidene)-2,3-dihydro-1H-indole-5-sulphonamide

C19H21N3O3S (371.1304)


   

Maybridge4_001514

Maybridge4_001514

C19H21N3O3S (371.1304)


   

N,N-dimethyl-2-oxo-3-(4,5,6,7-tetrahydro-1H-indol-2-ylmethylidene)-1H-indole-5-sulfonamide

N,N-dimethyl-2-oxo-3-(4,5,6,7-tetrahydro-1H-indol-2-ylmethylidene)-1H-indole-5-sulfonamide

C19H21N3O3S (371.1304)


   

SU 6656

2,3-dihydro-N,N-dimethyl-2-oxo-3-[(4,5,6,7-tetrahydro-1H-indol-2-yl)methylene]-1H-indole-5-sulfonamide

C19H21N3O3S (371.1304)


SU6656 is a Src family kinases inhibitor with IC50s of 280, 20, 130, 170 nM for Src, Yes, Lyn, and Fyn, respectively. SU6656 inhibits FAK phosphorylation at Y576/577, Y925, Y861 sites. SU6656 also inhibits p-AKT.

   

SU6656

(3z)-N,N-Dimethyl-2-Oxo-3-(4,5,6,7-Tetrahydro-1h-Indol-2-Ylmethylidene)-2,3-Dihydro-1h-Indole-5-Sulfonamide

C19H21N3O3S (371.1304)


SU6656 is a Src family kinases inhibitor with IC50s of 280, 20, 130, 170 nM for Src, Yes, Lyn, and Fyn, respectively. SU6656 inhibits FAK phosphorylation at Y576/577, Y925, Y861 sites. SU6656 also inhibits p-AKT.

   

N-[4-[(1,2-dimethyl-5-indolyl)methylsulfamoyl]phenyl]acetamide

N-[4-[(1,2-dimethyl-5-indolyl)methylsulfamoyl]phenyl]acetamide

C19H21N3O3S (371.1304)


   

(R)-N-(3-Indol-1-YL-2-methyl-propyl)-4-sulfamoyl-benzamide

(R)-N-(3-Indol-1-YL-2-methyl-propyl)-4-sulfamoyl-benzamide

C19H21N3O3S (371.1304)


   

(S)-N-(3-Indol-1-YL-2-methyl-propyl)-4-sulfamoyl-benzamide

(S)-N-(3-Indol-1-YL-2-methyl-propyl)-4-sulfamoyl-benzamide

C19H21N3O3S (371.1304)


   

N-[2-(1H-Indol-5-YL)-butyl]-4-sulfamoyl-benzamide

N-[2-(1H-Indol-5-YL)-butyl]-4-sulfamoyl-benzamide

C19H21N3O3S (371.1304)


   

4-hydroxy-1-(3-methylbutyl)-N-(5-methyl-1,3-thiazol-2-yl)-2-oxo-1,2-dihydroquinoline-3-carboxamide

4-hydroxy-1-(3-methylbutyl)-N-(5-methyl-1,3-thiazol-2-yl)-2-oxo-1,2-dihydroquinoline-3-carboxamide

C19H21N3O3S (371.1304)


   

5-(2,3-Dihydroindol-1-ylsulfonyl)-1,3-diethyl-2-benzimidazolone

5-(2,3-Dihydroindol-1-ylsulfonyl)-1,3-diethyl-2-benzimidazolone

C19H21N3O3S (371.1304)


   

[4-[[4-(Methylthio)phenyl]methyl]-1-piperazinyl]-(4-nitrophenyl)methanone

[4-[[4-(Methylthio)phenyl]methyl]-1-piperazinyl]-(4-nitrophenyl)methanone

C19H21N3O3S (371.1304)


   

3-Methyl-1-phenyl-5-thieno[2,3-c]pyrazolecarboxylic acid [2-(butylamino)-2-oxoethyl] ester

3-Methyl-1-phenyl-5-thieno[2,3-c]pyrazolecarboxylic acid [2-(butylamino)-2-oxoethyl] ester

C19H21N3O3S (371.1304)


   

5-(dimethylamino)-N-[4-(hydroxyamino)benzyl]naphthalene-1-sulfonamide

5-(dimethylamino)-N-[4-(hydroxyamino)benzyl]naphthalene-1-sulfonamide

C19H21N3O3S (371.1304)


   

N,N-dimethyl-2-oxo-3-(4,5,6,7-tetrahydro-1H-indol-2-ylmethylene)indoline-5-sulfonamide

N,N-dimethyl-2-oxo-3-(4,5,6,7-tetrahydro-1H-indol-2-ylmethylene)indoline-5-sulfonamide

C19H21N3O3S (371.1304)